ArticleMedicine2025
Appendiceal goblet cell adenocarcinoma synchronous with ascending colon adenocarcinoma and severe anemia: A case report.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Rare double primary carcinoma in ileocecal region: cecal tubular adenocarcinoma combined with appendiceal goblet cell adenocarcinoma.Diagnostic pathology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
rationaleAppendiceal goblet cell adenocarcinoma (AGCA) synchronous with colorectal cancer (CRC) is extremely rare, with only a few cases reported in the literature. The oncogenic mechanisms, diagnosis, and treatment of the coexistence of AGCA and CRC face significant challenges. This case report describes a patient diagnosed with ascending colon adenocarcinoma and severe anemia. Pathological examination after radical right hemicolectomy revealed goblet cell adenocarcinoma in the appendix. The patient subsequently received postoperative chemotherapy, and the prognosis was favorable. PATIENT CONCERNS: A 61-year-old female presented with abdominal pain and distension lasting over 6 months and was admitted to the hospital with a red blood cell count of 2.5 × 109/L and hemoglobin levels of 55.00 g/L. DIAGNOSES: Abdominal computed tomography demonstrated thickening of the ascending colon, raising suspicion of a colon tumor, and no abnormality in the appendix. Colonoscopy confirmed the presence of a mass in the ascending colon, and the biopsy results suggested adenocarcinoma. The preoperative diagnosis was ascending colon adenocarcinoma with severe anemia.
interventionsAfter a multidisciplinary discussion, the patient underwent radical right hemicolectomy under general anesthesia. OUTCOMES: Postoperative pathology revealed ascending colon adenocarcinoma and AGCA. The patient subsequently received postoperative chemotherapy, and the prognosis was favorable. LESSONS: Synchronous AGCA with CRC are rare. The oncogenic mechanisms, diagnosis, and treatment of the coexistence of AGCA and CRC face significant challenges, and radical tumor resection combined with postoperative chemotherapy is an important treatment strategy. We contend that for patients with AGCA combined with ascending colon adenocarcinoma, radical right hemicolectomy is a reasonable approach, as it allows for the simultaneous radical resection of tumors in both locations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.